Harmony Biosciences Reports Third Quarter 2021 Financial Results and Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Harmony Biosciences (HRMY) Files Mixed Shelf
November 9, 2021 4:04 PM ESTHarmony Biosciences (NASDAQ: HRMY) files mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Harmony Biosciences (HRMY) Tops Q3 EPS by 22c
November 9, 2021 7:32 AM ESTHarmony Biosciences (NASDAQ: HRMY) reported Q3 EPS of $0.51, $0.22 better than the analyst estimate of $0.29. Revenue for the quarter came in at $80.7 million versus the consensus estimate of $80.92 million.
For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.
... More